Weekly Tech+Bio Highlights #74: Big Pharma AI Tie-Ups Lean Toward Real-World Data
Quick run of pharma-AI collaborations, a new startup based on Google's cell sentence tech, and $100 genome sequencing from San Diego
This past week’s pattern was a cluster of big-pharma and large healthcare collaborations that pull AI closer to multimodal biological and clinical data, and closer to lab and development workflows, with several deals pointing at “model plus measurement” loops.
Separately, a new benchtop sequencer announcement from San Diego kept the “falling sequencing …


